ストックスクリーナーアプリを入手
1.29
4.03%
0.05
アフターアワーズ：
1.24
-0.05
-3.88%
前日終値:
$1.24
開ける：
$1.24
24時間の取引高:
529.98K
Relative Volume:
1.72
時価総額：
$68.96M
収益：
-
当期純損益:
$-78.34M
株価収益率:
-0.8705
EPS:
-1.4819
ネットキャッシュフロー:
$-75.02M
1週間 パフォーマンス:
+5.74%
1か月 パフォーマンス:
+10.26%
6か月 パフォーマンス:
-14.00%
1年 パフォーマンス:
-10.42%
1日の値動き範囲:
$1.24
$1.35
1週間の範囲:
$1.115
$1.35
52週間の値動き範囲:
$1.02
$1.88
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
名前
Pmv Pharmaceuticals Inc
セクター
電話
(609) 642-6670
住所
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.29 | 69.50M | 0 | -78.34M | -75.02M | -1.4819 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-05-13 | 開始されました | Craig Hallum | Buy |
| 2024-04-12 | 開始されました | Jefferies | Buy |
| 2023-12-27 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-02 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-09-22 | アップグレード | Goldman | Neutral → Buy |
| 2021-08-19 | 開始されました | Oppenheimer | Perform |
| 2021-08-02 | 開始されました | Guggenheim | Buy |
| 2021-07-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-10-20 | 開始されました | Cowen | Outperform |
| 2020-10-20 | 開始されました | Evercore ISI | Outperform |
| 2020-10-20 | 開始されました | Goldman | Neutral |
すべてを表示
Pmv Pharmaceuticals Inc (PMVP) 最新ニュース
ETFs Investing in PMV Pharmaceuticals, Inc. Stocks - TradingView
PMV (PMVP) Latest Quarter: The Available Earnings Metric Delivers a Beat in the Latest Reading; Closing Move: The Stock Records a 3.23% Increase on the DayAnalyst Coverage Count - vinanet.vn
PMV Pharmaceuticals (PMVP) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Pmv Pharmaceuticals Inc (NASDAQ: PMVP) Share Price, PMVP Stock News, PMVP Share Price & Updates - Kalkine
PMV Pharmaceuticals (NASDAQ:PMVP) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
PMV Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Form 8K Pmv Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Canada
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - The Manila Times
PMV Pharma Reports $18.1 Million Second-Quarter Net Loss - Quiver Quantitative
PMV Pharmaceuticals (PMVP) flags going-concern risk as rezatapopt advances toward NDA - Stock Titan
PMVP: Net loss narrowed, but liquidity concerns persist as rezatapopt advances toward NDA submission - TradingView
Press Release: PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - Moomoo
OSTX Stock Price and Chart — AMEX:OSTX - tradingview.com
PMV Pharmaceuticals Inc (PMVP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PMV Pharmaceuticals Inc (PMVP) Stock News Today - TradingKey
PMVP Q2'26 Earnings: EPS estimate is (0.39) USD - TradingView
PMV Pharmaceuticals Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
PMV Pharmaceuticals (PMVP) Projected to Announce Earnings on Thursday - MarketBeat
PMV Pharmaceuticals Inc (PMVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sio Capital discloses 4.94% PMV Pharmaceuticals (PMVP) stake below 5% threshold - Stock Titan
PMV Pharmaceuticals Inc (PMVP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PMV Pharmaceuticals Inc (PMVP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PMV Pharmaceuticals Inc (PMVP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.140|Chg%:+0.020 - TradingKey
PMV Pharmaceuticals Inc (PMVP) Earnings Date & Reports & Earnings News - TradingKey
TradingKey - TradingKey
PMV Pharmaceuticals Inc (PMVP) Valuation: PE, PB & Fair Value Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Institutional Confidence - TradingKey
PMV Pharmaceuticals Inc (PMVP) Income Statement - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.240|Chg%:-0.090 - TradingKey
PMV Pharmaceuticals Inc (PMVP) Cash Flow - TradingKey
PMV Pharmaceuticals Inc (PMVP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.180|Chg%:-0.060 - TradingKey
PMV Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:PMVP - TradingView
ArrowMark Colorado Holdings LLC Reduces Stake in PMV Pharmaceuti - GuruFocus
ArrowMark Colorado Holdings LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus
PMV Pharmaceuticals (PMVP) Declines 7.86% as Stock Tests Key Support LevelsPositive Gamma - Vinanet
PMV Pharmaceuticals (PMVP) Holds Steady at $1.42 as Trading Range TightensBreakout Confirmation - vinanet.vn
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
PMV Pharmaceuticals (PMVP) Holds Steady Near Support as Consolidation ContinuesStraddle Setup - DonanımHaber
ArrowMark Colorado Holdings (PMVP) holds 3.67% stake in PMV Pharmaceuticals - Stock Titan
PMV Pharmaceuticals Coverage Assumed by Ladenburg Thalmann at Buy - Moomoo
PMV Pharmaceuticals Price Target Announced at $3.00/Share by Ladenburg Thalmann - Moomoo
PMV Pharmaceuticals outlines its cancer drug pipeline as shares trade quietly - Ad-hoc-news.de
PMV Pharmaceuticals (PMVP) upgraded to buy: Here's why - MSN
PMV Pharmaceuticals holds the focus as investors await the next catalyst. - Ad-hoc-news.de
July 2026's Spotlight On Promising Penny Stocks - Sahm
PMV Pharmaceuticals Q1 2026 Earnings: EPS Beat on Cost Control as Pre-Revenue Biotech Advances PipelineFinal Results - dars.gov.et
Enterprise value to EBITDA forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Price to earnings forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Pmv Pharmaceuticals Inc (PMVP) 財務データ
収益
当期純利益
現金流量
EPS
Pmv Pharmaceuticals Inc (PMVP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):